Company Profile For Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (4502.T) (Tokyo Stock Exchange)

sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·

As of 11:30am IST

3,540JPY

Price Change

+20

Percent Change

+0.57%

Analyst Recommendations

Overview

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications and vitamin drops. The Health Care segment is engaged in the manufacture and sale of general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. The Company has 49 subsidiaries and 15 associated companies.

Quick Financial Synopsis

BRIEF: For the six months ended 30 September 2009, Takeda Pharmaceutical Company Limited's revenues decreased 6% to Y755.45B. The Company's net income totaled Y189.63B, up from an income of Y71.79B. Revenues reflect lower sales from pharmaceutical and other business segments. Net income benefits from lower percentages of sales cost and selling, general & admin expenses, as well as the presence of Y2.64B foreign exchange gains.